Related Experiment Video
Updated: Aug 9, 2025

11:31
Repair of a Critical-sized Calvarial Defect Model Using Adipose-derived Stromal Cells Harvested from Lipoaspirate
Published on: October 31, 2012
16.0K
Adipose Stem Cells in Modern-Day Ophthalmology
Mutali Musa1, Marco Zeppieri2, Ehimare S Enaholo3
1Department of Optometry, University of Benin, Benin City 300238, Nigeria.
Clinics and Practice
|February 24, 2023
Summary
Adipose-tissue-derived stem cells (ADSCs) show promise for regenerating damaged eye tissues. This review explores their therapeutic potential, extraction methods, and future applications in ophthalmic patient care.
Area of Science:
- Ophthalmology
- Regenerative Medicine
- Cell Biology
Background:
- Stem cells (SCs) are increasingly vital in ophthalmology, with classifications including embryonic, mesenchymal, tissue-specific, and induced pluripotent cells.
- Research spans animal models and human studies, highlighting SC potential for tissue regeneration and repair.
- Adipose tissue is a source of mesenchymal stem cells (MSCs), specifically adipose-tissue-derived stem cells (ADSCs), with applications in the oculo-visual system.
Purpose of the Study:
- To review published data on adipose-tissue-derived stem cells (ADSCs) for ophthalmic applications.
- To examine the anatomy, physiology, and extraction of ADSCs for therapeutic understanding.
- To discuss the future potential and adverse effects of ADSC therapy in eye care.
Main Methods:
- Literature review of published data on ADSCs.
- Analysis of ADSC extraction processes from adipose tissue.
- Examination of ADSC applications in immune-modulatory, therapeutic, and regenerative treatments for ophthalmic conditions.
Main Results:
- ADSCs possess immune-modulatory, therapeutic, and regenerative properties relevant to eye conditions.
- Understanding ADSC anatomy, physiology, and extraction is crucial for their clinical application.
- Published data supports the potential of ADSCs in treating various ophthalmic issues.
Conclusions:
- Adipose-tissue-derived stem cells (ADSCs) represent a promising therapeutic avenue for ophthalmic patient care.
- Further research into ADSC applications and safety is warranted for widespread clinical adoption.
- ADSC therapy offers a novel approach to regenerating and repairing damaged ocular tissues.

